The newly Active Pharmaceutical Ingredients (API) market report provided a complete view of the present and future market. Deep analysis of enterprise competition pattern, enterprise product advantages and disadvantages, regional industrial layout characteristics. The base year considered for the study is 2018 and the market size is projected from 2019 to 2026.
Product Information
Any substance or mixture of substances intended for use in the manufacture of pharmaceuticals, and when used in pharmaceuticals, becomes an active ingredient of pharmaceuticals. Such substances may have pharmacological activity or other direct effects in the diagnosis, treatment, symptom relief, treatment or prevention of the disease, or may affect the function or structure of the body.
On the basis of products, the various types include Synthetic Chemical API, Biological API, and HPAPI. On the basis of application, the Active Pharmaceutical Ingredients (API) market is segmented into Anti-infectives, Oncology, Cardiovascular and hematopoietic system, Central nervous system, Respiratory system, Gastrointestinal, Hormonal related disorders, Metabolic disorders, Genito-urinary disorders, Musculoskeletal disorders, and Other Therapeutics Uses.
Get FREE Sample of Active Pharmaceutical Ingredients (API) Market Report at:
Market Insights
The global Active Pharmaceutical Ingredients market is expected to increase from USD 182 million in 2019 to USD 283 million by 2026, registering a CAGR of 6.49% from 2019 to 2026. The growth can be mainly attributed to Advancements in API manufacturing and growth of the biopharmaceutical sector. Moreover, the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are also projected to propel the growth of the market. Increasing geriatric population across the globe is expected to promote the growth of the market. However, unfavorable drug price control policies and the growing popularity of counterfeit drugs can pose a challenge to market growth.
Regional Segment Analysis
The report focuses on detailed analysis of major regions like North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia), and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
In 2018, the global Active Pharmaceutical Ingredients market was mainly concentrated in the regions of Asia-Pacific, North America, and Europe, with the market share of 39.37%, 28.54%, and 24.67% respectively, accounting for a total of 92.58%. Major factors contributing to the growth of the global Active Pharmaceutical Ingredients market in these regions include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. North America is the largest producer with a proportion of 34.57% due to new technological breakthroughs along with new product developments.
Purchase a copy of Active Pharmaceutical Ingredients (API) report at:
Competitive Players
The Active Pharmaceutical Ingredients (API) market is full of competition due to the presence of many large and small companies and local manufacturers. The leading vendors in the market are Albemarle Corporation, Aurobindo Pharma Limited, Boehringer Ingelheim GmbH, Fresenius Kabi, and Lupin Pharmaceuticals Inc. Other prominent vendors in the market are Teva Pharmaceutical Industries LTD, Lonza Group, Novartis AG, Sun Pharmaceutical Industries LTD, and others.
Target Audience for this Report
l Active Pharmaceutical Ingredients (API) manufacturers
l Active Pharmaceutical Ingredients (API) importers and exporters
l Active Pharmaceutical Ingredients (API) traders, distributors, and suppliers
l Raw material suppliers of Active Pharmaceutical Ingredients (API)
l Active Pharmaceutical Ingredients (API) industry associations
l Product managers, Active Pharmaceutical Ingredients (API) industry administrator, C-level executives of the industries
l Market Research and consulting firms
l Healthcare organizations
l Research & Clinical Laboratories
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Active Pharmaceutical Ingredients (API) Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Active Pharmaceutical Ingredients (API) Market by Types
4 Segmentation of Active Pharmaceutical Ingredients (API) Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Active Pharmaceutical Ingredients (API) Market in Major Countries
7 North America Active Pharmaceutical Ingredients (API) Landscape Analysis
8 Europe Active Pharmaceutical Ingredients (API) Landscape Analysis
9 Asia Pacific Active Pharmaceutical Ingredients (API) Landscape Analysis
10 Latin America, Middle East & Africa Active Pharmaceutical Ingredients (API) Landscape Analysis
11 Major Players Profile
11.1 Albemarle Corporation
11.1.1 Albemarle Corporation Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Aurobindo Pharma Limited
11.3 Boehringer Ingelheim GmbH
11.4 Fresenius Kabi
11.5 Lupin Pharmaceuticals Inc.
11.6 Teva Pharmaceutical Industries LTD
11.7 Lonza Group
11.8 Novartis AG
11.9 Sun Pharmaceutical Industries LTD
…
Ask for a discount at:
Key questions answered in the report
l What will the market size and growth rate be in 2026?
l What segment or region will drive or lead the market growth and what are the reasons?
l How will market drivers, constraints and future opportunities affect market dynamics and subsequent analysis of relevant trends?
l What key strategies are used by top vendors to increase revenue?
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese